METTL3/ALKBH5‐Mediated N6‐Methyladenosine Modification Drives Macrophage M1 Polarization via the SLC15A3‐TASL‐IRF5 Signaling Axis in Psoriasis
Advanced Science · 2025-09 · 12 (36)
DOI: 10.1002/advs.202501408 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.07.2025. Verfasst von Tao Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China. Hauptthemen laut MEDLINE: Psoriasis, Macrophages, Adenosine, Interferon Regulatory Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Major Project of Guangzhou National Laboratory.
Abstract (Originalsprache)
Impaired N6‐methyladenosine (m 6 A) modification has been implicated in regulating various inflammatory diseases, but its role in psoriasis remains unclear. Here, m 6 A modification and its methyltransferase METTL3 are revealed to be upregulated in psoriatic macrophages, while the demethylase ALKBH5 is downregulated. Conditional knockout of Mettl3 in macrophages alleviated psoriasis‐like symptoms in mice, whereas knockout of Alkbh5 exacerbated them. Both in vivo and in vitro, Mettl3 deficiency inhibited IMQ‐induced M1 macrophage polarization, while Alkbh5 deficiency promoted M1 polarization. The regulation of macrophage polarization by m 6 A is likely mediated by targeting Slc15a3 . SLC15A3 enhances the recruitment of TASL, a recently identified endolysosomal IRF5 adaptor, which functions similarly to the IRF3 adaptors STING and MAVS at the endoplasmic reticulum (ER) and mitochondria, respectively, to augment IRF5 signaling via SLC15A4. The findings underscore the critical role of m 6 A RNA modification in psoriasis pathogenesis and unveil a novel regulatory mechanism of TASL‐IRF5 signaling through m 6 A modification, suggesting potential new therapeutic targets for psoriasis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.
- Cancer Research Institute, School of Basic Medical Sciences, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, Southern Medica…
- MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong, 510275, China.
ORCID-Profile: Tao Huang, Shijun Chen, Ke Ding, Liyan Yuan, Weiqi Lv, Kechen Chen, Yuchen Liu, Dongzhao Ma, Xin Zhang, Xiaobo Wang, Guanzheng Luo, Bin Yang, Ying Lin, Zhili Rong
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Major Project of Guangzhou National Laboratory
- Guangzhou Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Key Research and Development Program of China
Zitieren
APA
Huang, T., Chen, S., Ding, K., Yuan, L., Lv, W., Chen, K., Liu, Y., Ma, D., Zhang, X., Wang, X., Luo, G., Yang, B., Lin, Y., & Rong, Z. (2025). METTL3/ALKBH5‐Mediated N6‐Methyladenosine Modification Drives Macrophage M1 Polarization via the SLC15A3‐TASL‐IRF5 Signaling Axis in Psoriasis. Advanced Science, 12(36). https://doi.org/10.1002/advs.202501408
Vancouver
Huang T, Chen S, Ding K, Yuan L, Lv W, Chen K, et al. METTL3/ALKBH5‐Mediated N6‐Methyladenosine Modification Drives Macrophage M1 Polarization via the SLC15A3‐TASL‐IRF5 Signaling Axis in Psoriasis. Advanced Science. 2025;12(36). doi:10.1002/advs.202501408
BibTeX
@article{Huang2025,
author = {Huang, Tao and Chen, Shijun and Ding, Ke and Yuan, Liyan and Lv, Weiqi and Chen, Kechen and Liu, Yuchen and Ma, Dongzhao and Zhang, Xin and Wang, Xiaobo and Luo, Guanzheng and Yang, Bin and Lin, Ying and Rong, Zhili},
title = {METTL3/ALKBH5‐Mediated N6‐Methyladenosine Modification Drives Macrophage M1 Polarization via the SLC15A3‐TASL‐IRF5 Signaling Axis in Psoriasis},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {36},
doi = {10.1002/advs.202501408}
}
EUVIMED